The global surgical robotics market, valued at USD 5.84 billion in 2024, is projected to more than double, reaching USD 15.25 billion by 2033 at a CAGR of 11.3 percent, according to a report by DataM Intelligence.

Growth is even sharper in the broader field of robotic-assisted procedures, forecast to surge from USD 11.19 billion in 2024 to USD 42.21 billion by 2032, reflecting a robust 17.9 percent CAGR.

North America leads the market due to high adoption rates and technological innovation. The region accounts for nearly half of global revenues in 2024. The US surgical robotics and navigation market reached USD 6.3 billion in 2023, accounting for 90 percent of the overall surgery-and-navigation segment, and is projected to expand at a 15.4 percent CAGR, reaching USD 18.9 billion by 2030.

The Asia-Pacific region has emerged as the fastest-growing regional market for surgical robotics, propelled by infrastructure expansion, healthcare investment, and increased adoption of minimally invasive surgery. The region holds a 23.5 percent market share in 2024, with countries like China, India, Japan, and South Korea driving forward the regional surge in demand and deployment, supported by large patient populations, rising disposable incomes, and modernisation of healthcare facilities.

Japan represents a key growth engine within Asia-Pacific. Its surgical robotics market, estimated at USD 375 million in 2024, is expected to rise to USD 808.6 million by 2030, implying a 13.1 percent CAGR through the forecast period. Other estimates place Japan’s 2024 value at USD 318 million, with potential expansion to USD 876 million by 2033, reflecting an 11.9 percent CAGR. The Japanese government's initiatives, such as the Future Medical Technology Strategy, are accelerating robotic adoption, with over 25 percent of urban hospitals now equipped with robotic systems.

“Surgical robotics is entering a new phase: the US leads with volume and infrastructure; Japan delivers steady innovation alongside a health-conscious population; but Asia-Pacific is where scale and growth are fastest. Companies that integrate autonomy, broaden procedural coverage, and align with government innovation strategies will lead global adoption,” said the DataM research team.

The report cited the increasing demand for minimally invasive procedures, advancements in medical technology (3D visualization, AI integration, haptic feedback systems, and advanced imaging technologies), and the growing prevalence of chronic conditions such as arthritis among an aging population as key drivers of the global surgical robotics market.

Surgical robots improve precision, reduce recovery time, and minimise complications, making them attractive to healthcare providers and patients.

Orthopedics is emerging as a strong application area, particularly in joint replacement procedures for knee osteoarthritis.

However, the report noted that high costs remain a barrier, hindering market penetration and creating disparities in access to advanced robotic surgical care across different regions and healthcare systems.

The major players in the global surgical robotics market include: Johnson & Johnson MedTech, Abbott Laboratories, Stryker Corporation, Medtech Surgical, THINK Surgical, Asensus Surgical, CMR Surgical, Stereotaxis, Distalmotion, EndoQuest Robotics, and Medicaroid Corporation.

Johnson & Johnson MedTech recently completed its first clinical cases using its new OTTAVA Robotic Surgical System in gastric bypass procedures, with a De Novo FDA submission panned for soft-tissue surgery.

Stryker showcased its next-generation Mako SmartRobotics platforms for spine and shoulder procedures at AAOS, with full US commercial launch slated for late 2025.

MicroPort’s Toumai Endoscopic Surgical Robot, featuring four robotic arms, tremor filtration, and advanced dexterity controls, earned the Breakthrough Technology Award in 2025.

In March 2025, SS Innovations, the creator of India's first indigenous surgical robotic system, SSI Mantra, introduced the SSI Mantra 3, the most advanced version of the Mantra system, aimed at making advanced robotic surgeries cost-effective and accessible globally.